Sellas Life Sciences Group Inc. (SLS) at a glance

Sellas Life Sciences Group Inc. (SLS) is a Healthcare company. It trades at $7.7. It does not pay a dividend. Vestovix scores it 52/100 overall. Its strongest dimension is Momentum (70/100) and its weakest is Income (40/100).

Price
$7.70
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$1.39 to $9.51
Vestovix Score52/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
70